Glaxo Grp Ltd Drug Patent Portfolio
Glaxo Grp Ltd owns 9 orange book drugs protected by 65 US patents with Advair Diskus 100/50 having the least patent protection, holding only 2 patents. And Flovent Hfa with maximum patent protection, holding 41 patents. Given below is the list of Glaxo Grp Ltd's drug patents along with their expiration dates.
Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
---|---|---|---|
US8746242 | Medicament dispenser | 11 Apr, 2031 | Active |
US8746242 | Medicament dispenser | 11 Oct, 2030 | Active |
US8534281 | Manifold for use in medicament dispenser | 08 Sep, 2030 | Active |
US8534281 | Manifold for use in medicament dispenser | 08 Mar, 2030 | Active |
US11116721 | Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol | 26 Aug, 2029 | Active |
US11116721 | Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol | 26 Feb, 2029 | Active |
US8161968 | Medicament dispenser | 05 Aug, 2028 | Active |
US8113199 | Counter for use with a medicament dispenser | 23 Apr, 2028 | Active |
US9333310 | Medicament dispenser | 02 Apr, 2028 | Active |
US8161968 | Medicament dispenser | 05 Feb, 2028 | Active |
US8511304 | Medicament dispenser | 14 Dec, 2027 | Active |
US8113199 | Counter for use with a medicament dispenser | 23 Oct, 2027 | Active |
US9333310 | Medicament dispenser | 02 Oct, 2027 | Active |
US8511304 | Medicament dispenser | 14 Jun, 2027 | Active |
US7500444 | Actuation indicator for a dispensing device | 26 Aug, 2026 | Active |
US7500444 | Actuation indicator for a dispensing device | 26 Feb, 2026 | Active |
US7439393 | Phenethanolamine derivatives for treatment of respiratory diseases | 21 Nov, 2025 | Active |
US7439393 | Phenethanolamine derivatives for treatment of respiratory diseases | 21 May, 2025 | Active |
US7832351 | Actuation indicator for a dispensing device | 19 Dec, 2023 | Expired |
US7832351 | Actuation indicator for a dispensing device | 19 Jun, 2023 | Expired |
US7361787 | Phenethanolamine derivatives for treatment of respiratory diseases | 23 Mar, 2023 | Expired |
USRE44874 | Phenethanolamine derivatives for treatment of respiratory diseases | 23 Mar, 2023 | Expired |
US7776895 | Inhalation devices for delivering phenethanolamine derivatives for the treatment of respiratory diseases | 11 Sep, 2022 | Expired |
US6743413 | Suspension aerosol formulations | 01 Dec, 2021 | Expired |
US6537983 | Anti-inflammatory androstane derivatives | 03 Aug, 2021 | Expired |
US6759398 | Anti-inflammatory androstane derivative | 03 Aug, 2021 | Expired |
US6878698 | Anti-inflammatory androstane derivatives | 03 Aug, 2021 | Expired |
US7101866 | Anti-inflammatory androstane derivative | 03 Aug, 2021 | Expired |
US7629335 | Anti-inflammatory androstane derivative | 03 Aug, 2021 | Expired |
US6743413 | Suspension aerosol formulations | 01 Jun, 2021 | Expired |
US9861771 | Device housing for an aerosol container | 11 Oct, 2020 | Expired |
US7107986 | Dispenser with doses' counter | 08 Dec, 2019 | Expired |
US7350676 | Valve for aerosol container | 24 Feb, 2019 | Expired |
US6431168 | Dispenser with doses′ counter | 08 Dec, 2018 | Expired |
US7350676 | Valve for aerosol container | 24 Aug, 2018 | Expired |
US6161724 | Indicating device | 16 Jul, 2018 | Expired |
US6435372 | Delivery system for a medicament and method for the assembly thereof | 16 Jul, 2018 | Expired |
US6938796 | Indicating device | 16 Jul, 2018 | Expired |
US6997349 | Indicating device | 16 Jul, 2018 | Expired |
US7143908 | Indicating device | 16 Jul, 2018 | Expired |
US6170717 | Valve for aerosol container | 23 Jun, 2018 | Expired |
US6315173 | Valve for aerosol container | 23 Jun, 2018 | Expired |
US6510969 | Valve for aerosol container | 23 Jun, 2018 | Expired |
US6966467 | Valve for aerosol container | 23 Jun, 2018 | Expired |
US6431168 | Dispenser with doses′ counter | 08 Jun, 2018 | Expired |
US7107986 | Dispenser with doses' counter | 08 Jun, 2018 | Expired |
US6161724 | Indicating device | 16 Jan, 2018 | Expired |
US6435372 | Delivery system for a medicament and method for the assembly thereof | 16 Jan, 2018 | Expired |
US6938796 | Indicating device | 16 Jan, 2018 | Expired |
US6997349 | Indicating device | 16 Jan, 2018 | Expired |
US7143908 | Indicating device | 16 Jan, 2018 | Expired |
US6170717 | Valve for aerosol container | 23 Dec, 2017 | Expired |
US6315173 | Valve for aerosol container | 23 Dec, 2017 | Expired |
US6510969 | Valve for aerosol container | 23 Dec, 2017 | Expired |
US6966467 | Valve for aerosol container | 23 Dec, 2017 | Expired |
US5873360 | Inhalation device | 23 Aug, 2016 | Expired |
US5873360 | Inhalation device | 23 Feb, 2016 | Expired |
US5674472 | Canisters containing aerosol formulations containing P134a and fluticasone propionate | 07 Apr, 2015 | Expired |
US5658549 | Aerosol formulations containing propellant 134a and fluticasone propionate | 19 Feb, 2015 | Expired |
US6596260 | Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol | 10 Feb, 2015 | Expired |
US5674472 | Canisters containing aerosol formulations containing P134a and fluticasone propionate | 07 Oct, 2014 | Expired |
US5658549 | Aerosol formulations containing propellant 134a and fluticasone propionate | 19 Aug, 2014 | Expired |
US6596260 | Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol | 10 Aug, 2014 | Expired |
US6251368 | Pharmaceutical aerosol formulation containing a particulate medicament, a propellant and substantially free of a surfactant | 04 Jun, 2013 | Expired |
US6251368 | Pharmaceutical aerosol formulation containing a particulate medicament, a propellant and substantially free of a surfactant | 04 Dec, 2012 | Expired |
Latest Legal Activities on Glaxo Grp Ltd's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Glaxo Grp Ltd.
Activity | Date | Patent Number |
---|---|---|
Payment of Maintenance Fee, 8th Year, Large Entity | 20 Oct, 2023 | US9333310 |
Payment of Maintenance Fee, 12th Year, Large Entity | 21 Sep, 2023 | US8161968 |
Payment of Maintenance Fee, 12th Year, Large Entity | 21 Jul, 2023 | US8113199 |
Payment of Maintenance Fee, 12th Year, Large Entity | 21 Apr, 2022 | US7832351 |
Payment of Maintenance Fee, 12th Year, Large Entity | 21 Apr, 2022 | US7832351 |
Expire Patent
Critical
| 14 Feb, 2022 | US9861771 |
Expire Patent
Critical
| 14 Feb, 2022 | US9861771 |
Payment of Maintenance Fee, 12th Year, Large Entity | 20 Jan, 2022 | US7776895 |
Payment of Maintenance Fee, 8th Year, Large Entity | 17 Nov, 2021 | US8746242 |
Patent Issue Date Used in PTA Calculation
Critical
| 14 Sep, 2021 | US11116721 |
Recordation of Patent Grant Mailed
Critical
| 14 Sep, 2021 | US11116721 |
Maintenance Fee Reminder Mailed
Critical
| 30 Aug, 2021 | US9861771 |
Maintenance Fee Reminder Mailed
Critical
| 30 Aug, 2021 | US9861771 |
Email Notification
Critical
| 26 Aug, 2021 | US11116721 |
Issue Notification Mailed
Critical
| 25 Aug, 2021 | US11116721 |
Glaxo Grp Ltd's Drug Patent Litigations
Glaxo Grp Ltd's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Jul 26, 2001, against patent number US6596260. The petitioner , challenged the validity of this patent, with BRUGGER et al as the respondent. Click below to track the latest information on how companies are challenging Glaxo Grp Ltd's patents.
Patent | Proceeding Filing Date | Status | Respondent | Petitioner |
---|---|---|---|---|
US6743413 | September, 2015 |
Terminated-Settled
(18 Nov, 2016)
| 3M Company | Mylan Pharmaceuticals Inc. |
US6596260 | July, 2001 |
Decision
(25 Sep, 2002)
| BRUGGER et al |
Glaxo Grp Ltd Drug Patents' Oppositions Filed in EPO
Glaxo Grp Ltd drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on May 08, 2014, by Vossius & Partner. This opposition was filed on patent number EP03731693A. Click below to reveal the latest opposition data.
Application | Filing Date | Opposition Party | Legal Status |
---|---|---|---|
EP06765149A | Apr, 2020 | ELKINGTON AND FIFE LLP | Patent maintained as amended |
EP09779096A | Feb, 2020 | SANDOZ AG | Granted and Under Opposition |
EP09779096A | Feb, 2020 | N.V. Nederlandsch Octrooibureau | Granted and Under Opposition |
EP09779096A | Feb, 2020 | Teva UK Limited | Granted and Under Opposition |
EP09779096A | Feb, 2020 | HGF Limited | Granted and Under Opposition |
EP09779096A | Feb, 2020 | Aera A/S | Granted and Under Opposition |
EP09779096A | Feb, 2020 | Gill Jennings & Every LLP | Granted and Under Opposition |
EP09779096A | Feb, 2020 | Dehns Ltd | Granted and Under Opposition |
EP09779096A | Feb, 2020 | Arven Ilac Sanayi Ve Ticaret A.S. | Granted and Under Opposition |
EP10178947A | Jun, 2015 | Teva UK Limited | Revoked |
EP03731693A | May, 2014 | Teva UK Limited | Opposition rejected |
EP03731693A | May, 2014 | Vossius & Partner | Opposition rejected |
Glaxo Grp Ltd's Family Patents
Glaxo Grp Ltd Drug List
Given below is the complete list of Glaxo Grp Ltd's drugs and the patents protecting them.
1. Advair Diskus 100/50
Advair Diskus 100/50 is protected by 2 patents, out of which all have expired. Check out its patent list below.
Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
---|---|---|---|
US5873360
(Pediatric)
| Inhalation device |
23 Aug, 2016
(8 years ago)
| Expired |
US5873360 | Inhalation device |
23 Feb, 2016
(8 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Advair Diskus 100/50's drug page
2. Advair Diskus 250/50
Advair Diskus 250/50 is protected by 2 patents, out of which all have expired. Check out its patent list below.
Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
---|---|---|---|
US5873360
(Pediatric)
| Inhalation device |
23 Aug, 2016
(8 years ago)
| Expired |
US5873360 | Inhalation device |
23 Feb, 2016
(8 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Advair Diskus 250/50's drug page
3. Advair Diskus 500/50
Advair Diskus 500/50 is protected by 2 patents, out of which all have expired. Check out its patent list below.
Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
---|---|---|---|
US5873360
(Pediatric)
| Inhalation device |
23 Aug, 2016
(8 years ago)
| Expired |
US5873360 | Inhalation device |
23 Feb, 2016
(8 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Advair Diskus 500/50's drug page
4. Advair Hfa
Advair Hfa is protected by 41 patents, out of which 37 have expired. Check out its patent list below.
Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
---|---|---|---|
US7500444
(Pediatric)
| Actuation indicator for a dispensing device |
26 Aug, 2026
(1 year, 10 months from now)
| Active |
US7500444 | Actuation indicator for a dispensing device |
26 Feb, 2026
(1 year, 4 months from now)
| Active |
US7500444
(Pediatric)
| Actuation indicator for a dispensing device |
04 Jul, 2025
(8 months from now)
| Active |
US7500444 | Actuation indicator for a dispensing device |
04 Jan, 2025
(2 months from now)
| Active |
US7832351
(Pediatric)
| Actuation indicator for a dispensing device |
19 Dec, 2023
(9 months ago)
| Expired |
US7832351 | Actuation indicator for a dispensing device |
19 Jun, 2023
(1 year, 3 months ago)
| Expired |
US6743413
(Pediatric)
| Suspension aerosol formulations |
01 Dec, 2021
(2 years ago)
| Expired |
US6743413 | Suspension aerosol formulations |
01 Jun, 2021
(3 years ago)
| Expired |
US9861771 | Device housing for an aerosol container |
11 Oct, 2020
(3 years ago)
| Expired |
US7350676
(Pediatric)
| Valve for aerosol container |
24 Feb, 2019
(5 years ago)
| Expired |
US6431168
(Pediatric)
| Dispenser with doses′ counter |
08 Dec, 2018
(5 years ago)
| Expired |
US7107986
(Pediatric)
| Dispenser with doses' counter |
08 Dec, 2018
(5 years ago)
| Expired |
US7350676 | Valve for aerosol container |
24 Aug, 2018
(6 years ago)
| Expired |
US6161724
(Pediatric)
| Indicating device |
16 Jul, 2018
(6 years ago)
| Expired |
US6435372
(Pediatric)
| Delivery system for a medicament and method for the assembly thereof |
16 Jul, 2018
(6 years ago)
| Expired |
US6938796
(Pediatric)
| Indicating device |
16 Jul, 2018
(6 years ago)
| Expired |
US6997349
(Pediatric)
| Indicating device |
16 Jul, 2018
(6 years ago)
| Expired |
US7143908
(Pediatric)
| Indicating device |
16 Jul, 2018
(6 years ago)
| Expired |
US6170717
(Pediatric)
| Valve for aerosol container |
23 Jun, 2018
(6 years ago)
| Expired |
US6315173
(Pediatric)
| Valve for aerosol container |
23 Jun, 2018
(6 years ago)
| Expired |
US6510969
(Pediatric)
| Valve for aerosol container |
23 Jun, 2018
(6 years ago)
| Expired |
US6966467
(Pediatric)
| Valve for aerosol container |
23 Jun, 2018
(6 years ago)
| Expired |
US6431168 | Dispenser with doses′ counter |
08 Jun, 2018
(6 years ago)
| Expired |
US7107986 | Dispenser with doses' counter |
08 Jun, 2018
(6 years ago)
| Expired |
US6161724 | Indicating device |
16 Jan, 2018
(6 years ago)
| Expired |
US6435372 | Delivery system for a medicament and method for the assembly thereof |
16 Jan, 2018
(6 years ago)
| Expired |
US6938796 | Indicating device |
16 Jan, 2018
(6 years ago)
| Expired |
US6997349 | Indicating device |
16 Jan, 2018
(6 years ago)
| Expired |
US7143908 | Indicating device |
16 Jan, 2018
(6 years ago)
| Expired |
US6170717 | Valve for aerosol container |
23 Dec, 2017
(6 years ago)
| Expired |
US6315173 | Valve for aerosol container |
23 Dec, 2017
(6 years ago)
| Expired |
US6510969 | Valve for aerosol container |
23 Dec, 2017
(6 years ago)
| Expired |
US6966467 | Valve for aerosol container |
23 Dec, 2017
(6 years ago)
| Expired |
US5674472
(Pediatric)
| Canisters containing aerosol formulations containing P134a and fluticasone propionate |
07 Apr, 2015
(9 years ago)
| Expired |
US5658549
(Pediatric)
| Aerosol formulations containing propellant 134a and fluticasone propionate |
19 Feb, 2015
(9 years ago)
| Expired |
US6596260
(Pediatric)
| Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol |
10 Feb, 2015
(9 years ago)
| Expired |
US5674472 | Canisters containing aerosol formulations containing P134a and fluticasone propionate |
07 Oct, 2014
(10 years ago)
| Expired |
US5658549 | Aerosol formulations containing propellant 134a and fluticasone propionate |
19 Aug, 2014
(10 years ago)
| Expired |
US6596260 | Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol |
10 Aug, 2014
(10 years ago)
| Expired |
US6251368
(Pediatric)
| Pharmaceutical aerosol formulation containing a particulate medicament, a propellant and substantially free of a surfactant |
04 Jun, 2013
(11 years ago)
| Expired |
US6251368 | Pharmaceutical aerosol formulation containing a particulate medicament, a propellant and substantially free of a surfactant |
04 Dec, 2012
(11 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Advair Hfa's drug page
5. Breo Ellipta
Breo Ellipta is protected by 25 patents, out of which 9 have expired. Check out its patent list below.
Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
---|---|---|---|
US8746242
(Pediatric)
| Medicament dispenser |
11 Apr, 2031
(6 years from now)
| Active |
US8746242 | Medicament dispenser |
11 Oct, 2030
(6 years from now)
| Active |
US8534281
(Pediatric)
| Manifold for use in medicament dispenser |
08 Sep, 2030
(5 years from now)
| Active |
US8534281 | Manifold for use in medicament dispenser |
08 Mar, 2030
(5 years from now)
| Active |
US11116721
(Pediatric)
| Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol |
26 Aug, 2029
(4 years from now)
| Active |
US11116721 | Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol |
26 Feb, 2029
(4 years from now)
| Active |
US8161968
(Pediatric)
| Medicament dispenser |
05 Aug, 2028
(3 years from now)
| Active |
US8113199
(Pediatric)
| Counter for use with a medicament dispenser |
23 Apr, 2028
(3 years from now)
| Active |
US9333310
(Pediatric)
| Medicament dispenser |
02 Apr, 2028
(3 years from now)
| Active |
US8161968 | Medicament dispenser |
05 Feb, 2028
(3 years from now)
| Active |
US8511304
(Pediatric)
| Medicament dispenser |
14 Dec, 2027
(3 years from now)
| Active |
US8113199 | Counter for use with a medicament dispenser |
23 Oct, 2027
(3 years from now)
| Active |
US9333310 | Medicament dispenser |
02 Oct, 2027
(2 years from now)
| Active |
US8511304 | Medicament dispenser |
14 Jun, 2027
(2 years from now)
| Active |
US7439393
(Pediatric)
| Phenethanolamine derivatives for treatment of respiratory diseases |
21 Nov, 2025
(1 year, 1 month from now)
| Active |
US7439393 | Phenethanolamine derivatives for treatment of respiratory diseases |
21 May, 2025
(7 months from now)
| Active |
US7361787 | Phenethanolamine derivatives for treatment of respiratory diseases |
23 Mar, 2023
(1 year, 6 months ago)
| Expired |
USRE44874 | Phenethanolamine derivatives for treatment of respiratory diseases |
23 Mar, 2023
(1 year, 6 months ago)
| Expired |
US7776895 | Inhalation devices for delivering phenethanolamine derivatives for the treatment of respiratory diseases |
11 Sep, 2022
(2 years ago)
| Expired |
US6537983 | Anti-inflammatory androstane derivatives |
03 Aug, 2021
(3 years ago)
| Expired |
US6759398 | Anti-inflammatory androstane derivative |
03 Aug, 2021
(3 years ago)
| Expired |
US6878698 | Anti-inflammatory androstane derivatives |
03 Aug, 2021
(3 years ago)
| Expired |
US7101866 | Anti-inflammatory androstane derivative |
03 Aug, 2021
(3 years ago)
| Expired |
US7629335 | Anti-inflammatory androstane derivative |
03 Aug, 2021
(3 years ago)
| Expired |
US5873360 | Inhalation device |
23 Feb, 2016
(8 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Breo Ellipta's drug page
Explore Our Curated Drug Screens
6. Flovent Diskus 100
Flovent Diskus 100 is protected by 2 patents, out of which all have expired. Check out its patent list below.
Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
---|---|---|---|
US5873360
(Pediatric)
| Inhalation device |
23 Aug, 2016
(8 years ago)
| Expired |
US5873360 | Inhalation device |
23 Feb, 2016
(8 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Flovent Diskus 100's drug page
7. Flovent Diskus 250
Flovent Diskus 250 is protected by 2 patents, out of which all have expired. Check out its patent list below.
Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
---|---|---|---|
US5873360
(Pediatric)
| Inhalation device |
23 Aug, 2016
(8 years ago)
| Expired |
US5873360 | Inhalation device |
23 Feb, 2016
(8 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Flovent Diskus 250's drug page
8. Flovent Diskus 50
Flovent Diskus 50 is protected by 2 patents, out of which all have expired. Check out its patent list below.
Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
---|---|---|---|
US5873360
(Pediatric)
| Inhalation device |
23 Aug, 2016
(8 years ago)
| Expired |
US5873360 | Inhalation device |
23 Feb, 2016
(8 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Flovent Diskus 50's drug page
9. Flovent Hfa
Flovent Hfa is protected by 41 patents, out of which 37 have expired. Check out its patent list below.
Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
---|---|---|---|
US7500444
(Pediatric)
| Actuation indicator for a dispensing device |
26 Aug, 2026
(1 year, 10 months from now)
| Active |
US7500444 | Actuation indicator for a dispensing device |
26 Feb, 2026
(1 year, 4 months from now)
| Active |
US7500444
(Pediatric)
| Actuation indicator for a dispensing device |
04 Jul, 2025
(8 months from now)
| Active |
US7500444 | Actuation indicator for a dispensing device |
04 Jan, 2025
(2 months from now)
| Active |
US7832351
(Pediatric)
| Actuation indicator for a dispensing device |
19 Dec, 2023
(9 months ago)
| Expired |
US7832351 | Actuation indicator for a dispensing device |
19 Jun, 2023
(1 year, 3 months ago)
| Expired |
US6743413
(Pediatric)
| Suspension aerosol formulations |
01 Dec, 2021
(2 years ago)
| Expired |
US6743413 | Suspension aerosol formulations |
01 Jun, 2021
(3 years ago)
| Expired |
US9861771 | Device housing for an aerosol container |
11 Oct, 2020
(3 years ago)
| Expired |
US7107986
(Pediatric)
| Dispenser with doses' counter |
08 Dec, 2019
(4 years ago)
| Expired |
US7350676
(Pediatric)
| Valve for aerosol container |
24 Feb, 2019
(5 years ago)
| Expired |
US6431168
(Pediatric)
| Dispenser with doses′ counter |
08 Dec, 2018
(5 years ago)
| Expired |
US7350676 | Valve for aerosol container |
24 Aug, 2018
(6 years ago)
| Expired |
US6161724
(Pediatric)
| Indicating device |
16 Jul, 2018
(6 years ago)
| Expired |
US6435372
(Pediatric)
| Delivery system for a medicament and method for the assembly thereof |
16 Jul, 2018
(6 years ago)
| Expired |
US6938796
(Pediatric)
| Indicating device |
16 Jul, 2018
(6 years ago)
| Expired |
US6997349
(Pediatric)
| Indicating device |
16 Jul, 2018
(6 years ago)
| Expired |
US7143908
(Pediatric)
| Indicating device |
16 Jul, 2018
(6 years ago)
| Expired |
US6170717
(Pediatric)
| Valve for aerosol container |
23 Jun, 2018
(6 years ago)
| Expired |
US6315173
(Pediatric)
| Valve for aerosol container |
23 Jun, 2018
(6 years ago)
| Expired |
US6510969
(Pediatric)
| Valve for aerosol container |
23 Jun, 2018
(6 years ago)
| Expired |
US6966467
(Pediatric)
| Valve for aerosol container |
23 Jun, 2018
(6 years ago)
| Expired |
US6431168 | Dispenser with doses′ counter |
08 Jun, 2018
(6 years ago)
| Expired |
US7107986 | Dispenser with doses' counter |
08 Jun, 2018
(6 years ago)
| Expired |
US6161724 | Indicating device |
16 Jan, 2018
(6 years ago)
| Expired |
US6435372 | Delivery system for a medicament and method for the assembly thereof |
16 Jan, 2018
(6 years ago)
| Expired |
US6938796 | Indicating device |
16 Jan, 2018
(6 years ago)
| Expired |
US6997349 | Indicating device |
16 Jan, 2018
(6 years ago)
| Expired |
US7143908 | Indicating device |
16 Jan, 2018
(6 years ago)
| Expired |
US6170717 | Valve for aerosol container |
23 Dec, 2017
(6 years ago)
| Expired |
US6315173 | Valve for aerosol container |
23 Dec, 2017
(6 years ago)
| Expired |
US6510969 | Valve for aerosol container |
23 Dec, 2017
(6 years ago)
| Expired |
US6966467 | Valve for aerosol container |
23 Dec, 2017
(6 years ago)
| Expired |
US5674472
(Pediatric)
| Canisters containing aerosol formulations containing P134a and fluticasone propionate |
07 Apr, 2015
(9 years ago)
| Expired |
US5658549
(Pediatric)
| Aerosol formulations containing propellant 134a and fluticasone propionate |
19 Feb, 2015
(9 years ago)
| Expired |
US6596260
(Pediatric)
| Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol |
10 Feb, 2015
(9 years ago)
| Expired |
US5674472 | Canisters containing aerosol formulations containing P134a and fluticasone propionate |
07 Oct, 2014
(10 years ago)
| Expired |
US5658549 | Aerosol formulations containing propellant 134a and fluticasone propionate |
19 Aug, 2014
(10 years ago)
| Expired |
US6596260 | Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol |
10 Aug, 2014
(10 years ago)
| Expired |
US6251368
(Pediatric)
| Pharmaceutical aerosol formulation containing a particulate medicament, a propellant and substantially free of a surfactant |
04 Jun, 2013
(11 years ago)
| Expired |
US6251368 | Pharmaceutical aerosol formulation containing a particulate medicament, a propellant and substantially free of a surfactant |
04 Dec, 2012
(11 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Flovent Hfa's drug page